Most recently, Solve Therapeutics raised $48.2M in its Early Stage VC (Nov 2025).
- ·The complete investor list: 16 names
- ·Watch Solve Therapeutics: the Monday email on marks, rounds and moves
Solve Therapeutics round by round
3 roundsHow much has Solve Therapeutics raised?
Solve Therapeutics has raised $385 million in total; 3 of its rounds are on record, from 2021 on. The largest on record was a $63.5 million later-stage round in Dec 2021; the most recent was a $48.2 million early-stage round in Nov 2025.
Solve Therapeutics has filed 3 Form Ds with the SEC since 2022, most recently in Nov 2025 ($48.2 million sold to 16 investors).
Solve Therapeutics investors
16 investors are on record for Solve Therapeutics, including University of California, Alexandria Venture Investments, General Atlantic and Ally Bridge Group. By type, the record holds 3 hedge funds and 2 growth equity firms. The early-stage round in Nov 2025 drew 16 investors.
16 investors have backed Solve Therapeutics.
Frequently asked about Solve Therapeutics
- How much has Solve Therapeutics raised?
- Solve Therapeutics has raised $384.5M in total across 3 recorded funding rounds.
- When was Solve Therapeutics's last funding round?
- Solve Therapeutics's most recent recorded round was Early Stage VC in Nov 2025, raising $48.2M.